Cancer immunotherapy Types of monoclonal antibodies Cancer immunotherapy:Monoclonal antibodies

| Antibody | Brand_name | Approval_date | Type_ | Target | Approved_treatments |
|---|---|---|---|---|---|
| Alemtuzumab | Campath | 2001 | humanized | CD52 | Chronic lymphocytic leukemia |
| Bevacizumab | Avastin | 2004 | humanized | vascular endothelial growth factor | colorectal cancer |
| Brentuximab vedotin | Adcetris | 2011 | chimeric | CD30 | Hodgkin lymphoma , Anaplastic large-cell lymphoma |
| Cetuximab | Erbitux | 2004 | chimeric | epidermal growth factor receptor | colorectal cancer |
| Gemtuzumab ozogamicin | Mylotarg | 2000 | humanized | CD33 | acute myelogenous leukemia (with calicheamicin ) |
| Panitumumab | Vectibix | 2006 | human | epidermal growth factor receptor | colorectal cancer |
| Rituximab | Rituxan, Mabthera | 1997 | chimeric | CD20 | non-Hodgkin lymphoma |